SUI Feasibility research in Viveve Medical, Inc. (NASDAQ:VIVE) showed Positive efficacy data and Preclinical outcomes that favor the Viveve’s New Sham Tip for Critical PURSUIT Trial

SUI Feasibility research in Viveve Medical, Inc. (NASDAQ:VIVE) showed Positive efficacy data and Preclinical outcomes that favor the Viveve’s New Sham Tip for Critical PURSUIT Trial

Viveve Medical, Inc. (NASDAQ:VIVE), is a medical technology company whose research area is women’s intimate health. The company has recently reported that its three arm feasibility study on five month Stress Urinary Incontinence (SUI), which was based on comparing the Viveve’s Cryogen-cooled Monopolar Radiofrequency (CMRF) treatment and a cryogen-only sham treatment to an inert sham treatment to restrain SUI in women ,has showed  primarily positive  data. Moreover the company also announced positive results from an…

Read More